Table 2 FDG-PET and FLT-PET Results
FDG-PET | FLT-PET | ||||||
|---|---|---|---|---|---|---|---|
Subject # | Treatment Cohort | Baseline Average SUVmax | Follow-up Average SUVmax | Metabolic Response | Baseline Average SUVmax | Follow-up Average SUVmax | Proliferative Response |
14 | Week 1 | 4.9 | 6.2 | PD | 6.9 | 8.4 | SD |
24 | Week 1 | 5.1 | 5.8 | SD | 5.5 | 5.9 | SD |
20 | Week 1 | 5.2 | 6.4 | SD | 7.4 | 5.3 | PR |
5 | Week 1 | 4.9 | 5.3 | SD | 4.5 | 2.8 | PR |
2 | Week 2 | 4.7 | 5.6 | SD | 4.7 | 4.5 | SD |
21 | Week 2 | 3.4 | 3.5 | SD | 6.2 | 3.1 | PR |
22 | Week 2 | 8.7 | 9.3 | SD | 6.8 | 6.7 | SD |
19 | Week 2 | 17.9 | 15.0 | SD | 7.8 | 5.6 | PR |
23 | Week 2 | 18.1 | 12.5 | PR | 5.0 | 5.3 | SD |
25 | Week 2 | 9.6 | 9.0 | SD | 5.8 | 6.2 | SD |
18 | Week 2 | 12.6 | 12.2 | SD | 8.4 | 5.1 | PR |
9 | Week 3 | 21.0 | 15.8 | SD | N/A | 5.3 | N/A |
15 | Week 3 | 6.0 | 4.2 | PR | 3.4 | 2.5 | PR |
16 | Week 3 | 10.9 | N/A | N/A | 9.7 | 12.7 | PD |
11 | Week 3 | 2.7 | 3.2 | SD | 1.3 | 1.4 | SD |
17 | Week 3 | 1.5 | 1.0 | PR | 0.7 | 0.4 | PR |
6 | Week 4 | 7.3 | 5.2 | PR | 5.1 | 2.1 | PR |
8 | Week 4 | 8.9 | 7.1 | SD | 14.6 | 7.5 | PR |
10 | Week 4 | 4.9 | 6.7 | PD | 5.1 | 5.9 | SD |
4 | Week 4 | 7.0 | 4.9 | PR | 5.3 | 5.0 | SD |